Literature DB >> 32521166

Clonally Related Viable Nontuberculous Mycobacteria in Gastric Juice and Sputum in People with Cystic Fibrosis.

Chris Ward1, Hafez Al Momani2, Audrey Perry3, John D Perry3, Amaran Krishnan4, Rhys Jones5, Mike Griffin6, Jeff Pearson1, Stephen Bourke7.   

Abstract

Entities:  

Mesh:

Year:  2020        PMID: 32521166      PMCID: PMC7528792          DOI: 10.1164/rccm.202005-1520LE

Source DB:  PubMed          Journal:  Am J Respir Crit Care Med        ISSN: 1073-449X            Impact factor:   21.405


× No keyword cloud information.
To the Editor: We congratulate Dawrs and colleagues for their investigation of a possible link between nontuberculous mycobacterial (NTM) pulmonary infections, gastro esophageal reflux, and microaspiration (1). The authors hypothesize that NTM may be deposited into the lung through extra esophageal reflux and microaspiration following intake from potable water systems and environmental sources (1). The investigators used in vitro modeling approaches and pH-adjusted laboratory mycobacterial cultures to investigate the susceptibility of human airway epithelial cells to NTM infection. This was thoroughly done by employing submerged epithelial cultures and cells differentiated at an air–liquid interface. The study showed that a reference strain of Mycobacterium abscessus (American Type Culture Collection 19977) remained viable at pH 4 and 7.5, using an in vitro model of gastric juice conditions (1). The M. abscessus complex (MABSC) is a major respiratory pathogen associated with accelerated decline in lung function and is a relative contraindication to lung transplantation in people with cystic fibrosis (CF) (2). We have previously shown that MABSC can be isolated from the gastric juice of people with CF fed by Percutaneous endoscopic gastrostomy. Clonally related clinical organisms were also isolated from matching sputum in patients with symptoms of extraesophageal reflux, who are routinely treated with antacid medication (3). Reports showing that gastric juice can be a useful clinical sample for diagnosing M. tuberculosis add plausibility to our finding that the gastric compartment may be a reservoir of viable NTM. Disruption of gastric barrier function, inherent to Percutaneous endoscopic gastrostomy surgery, has been associated with NTM infection (4). Apart from NTM, we have also shown clonally related, biofilm-forming Pseudomanas aeruginosa isolates in the gastric juice and sputum of people with CF who reported associated symptoms of extraesophageal reflux (5). Viable fungal and bacterial microorganisms apart from MABSC and P. aeruginosa can be isolated from gastric juice sourced at gastroscopy in patients without lung disease when pH exceeds 4 (6). We conclude that patient-derived gastric and airway sampling show the gastrointestinal compartment can be a reservoir for a range of microbiological organisms relevant to pulmonary diseases with exchange possible. Ex vivo patient findings compliment the in vitro study of Dawrs and colleagues and indicate that microaspiration of organisms including MABSC may constitute a microbiological challenge to the lung. More generally, we suggest that an increased awareness of integrated “aerodigestive” physiology and pathophysiology may be an important and timely area of research.
  4 in total

1.  Perigastrostomy infection caused by Mycobacterium abscessus in an immunocompetent patient.

Authors:  Hsien-Yi Chiu; Kao-Lang Liu; Yi-Hua Liao
Journal:  Acta Derm Venereol       Date:  2010       Impact factor: 4.437

2.  Mycobacterium abscessus and Gastroesophageal Reflux: An in vitro Study.

Authors:  Stephanie N Dawrs; Michelle Kautz; Edward D Chan; Jennifer R Honda
Journal:  Am J Respir Crit Care Med       Date:  2020-04-16       Impact factor: 21.405

3.  Microbiological profiles of sputum and gastric juice aspirates in Cystic Fibrosis patients.

Authors:  H Al-Momani; A Perry; C J Stewart; R Jones; A Krishnan; A G Robertson; S Bourke; S Doe; S P Cummings; A Anderson; T Forrest; S M Griffin; M Brodlie; J Pearson; C Ward
Journal:  Sci Rep       Date:  2016-06-01       Impact factor: 4.379

4.  Nontuberculous mycobacteria in gastrostomy fed patients with cystic fibrosis.

Authors:  H Al-Momani; A Perry; R Jones; S Bourke; S Doe; J Perry; A Anderson; T Forrest; I Forrest; M Griffin; M Brodlie; J Pearson; C Ward
Journal:  Sci Rep       Date:  2017-04-24       Impact factor: 4.379

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.